In general, the continuous administration of alfentanil for maintaining general anaesthesia is supplemented by nitrous oxide, volatile or i.v. anaesthetic agents. Various methods have been used for identifying the appropriate rate of infusion to maintain an adequate level of anaesthesia. Prys-Roberts and colleagues [1] proposed the term minimal infusion rate (MIR) as that rate of infusion at which 50 % of the patients do not respond to skin incision. MIR may be considered as a systematic approach to both establishing relative potencies and providing guidelines on dosage requirements. However, by definition it requires a response to skin incision. It has been suggested that a more useful approach would be for the anaesthetist to know the rate of administration which was successful, for instance, in 95 % of patients. A potential method of denning this rate of infusion may be the use of closed-loop feedback controlled drug delivery systems.
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Alfentanil decreases EEG frequency in a concentration-dependent manner [2] . The aim of this study was to identify, during alfentanil-nitrous oxide anaesthesia, the rate of infusion of alfentanil necessary to maintain a given slowing of EEG frequency.
PATIENTS AND METHODS
After obtaining institutional Ethics Committee approval and informed written consent, we studied 11 patients (ASA I, II) undergoing general surgery (table I) . Premedication consisted of pethidine 50 mg and promethazine 50 mg i.m. given 45 min before anaesthesia. Anaesthesia was induced with fentanyl 0.1 mg and thiopentone 300-500 mg, followed by suxamethonium 80 mg. The trachea was intubated and the lungs ventilated with 60 % nitrous oxide in oxygen for the duration of surgery. Neuromuscular block was maintained by administration of either repetitive bolus doses of pancuronium or continuous infusion of vecuronium to maintain a 90 % reduction in twitch response to a train-of-four stimulus. Patient monitoring consisted of ECG, automatic noninvasive arterial pressure (Dinamap) and end-tidal PcOj, (PE'CO.) (Hewlett-Packard 47210A). Artificial ventilation was adjusted to maintain PE' COJ at 4.5 kPa. Immediately before skin incision, a bolus of alfentanil 3 mg was given and the feedback control system for the administration of alfentanil activated. Alfentanil was administered via an indwelling cannula in the forearm by an infusion pump (Treonic, Vickers) which was interfaced to a computer (Eltec, Eurocom). During surgery, no other anaesthetic medication was administered.
EEG analysis
Four EEG leads (Cz-Fi, Cz-Oi; i = 1,2) were amplified (Mingograph Junior, Siemens) and recorded on magnetic tape (PR 2200 Ampex). The CzOi lead having the smaller impedance was used for deriving the feedback signal.
The filter settings of the EEG amplifier were 0.3 s and 70 Hz. Before A-D conversion, the signal was analogue filtered between 0.5 and 32 Hz, divided into epochs of 8.192 s and digitized at a rate of 125 Hz with 12 bit A-D resolution. Median EEG frequency of EEG power spectrum was used as feedback signal. We chose the interval 2-4 Hz as the set point for maintenance of anaesthesia [3, 4] . As the administration algorithm, we used a procedure described earlier [5] [6] [7] . This algorithm used an integrated pharmacokinetic-pharmacodynamic model to calculate the infusion strategy to set and maintain the desired effect. If measured median 
Definition of effective therapeutic infusions
Under the condition of linear pharmacokinetics, the amount of drug administered per unit time I(t) and the resulting concentration C(t) is given by:
The disposition function G(t) can be modelled for alfentanil by a biexponential function [8] :
G(t) = A exp(-at) + B exp(-yft)
Assuming that the maintenance of a constant effect, E, is associated with a constant concentration, C, it can be shown [9] that the cumulative amount D(t) = J* o dr' 7(i') to maintain E has the general form:
The asymptote of the cumulative dose requirement curve, D(t), is given by the function M x + /" t, where the unit /" obviously defines the slope of the asymptote. Given a feedback system which maintains a certain effect within the therapeutic window, the asymptote /" to the emerging cumulative dose curve, D(t), defines an effective therapeutic infusion [7, 10] . In this study, we used non-linear least square fitting to determine /^ from the foregoing formulae as an estimate of the effective therapeutic infusion of alfentanil. Table II summarizes the findings of quantitative EEG analysis. According to the desired set point of median EEG frequency of 2-4 Hz, the median EEG frequency varied between individuals in the range 2.2-3.6 Hz with a mean of 3.03 (SD 0.45) Hz. As can be identified from the resolution of the power spectrum into frequency bands, EEG slowing was caused largely by a frequency shift into the frequency band of 0.5-2 Hz which contained on average 40% of total EEG power. Edge frequency (95 % percentile of EEG power spectrum) was found to be 15.4 (3.1) Hz. Figure 1 depicts the typical time course of cumulative alfentanil requirement for a typical patient (No. 1) whose effective therapeutic infusion rate was assessed as 0.14 mg min" 1 . Figure 2 shows the time course of mean (SD) cumulative alfentanil requirement for all 11 patients for the first 120 min. The average cumulative amount for the first 120 min was 23.5 mg. Table III depicts the behaviour of arterial pressure and heart rate before anaesthesia, after skin incision and at the end of surgery and the corresponding values at greatest systolic and least diastolic arterial pressure measured during surgery. Table IV gives the individual effective therapeutic infusions for the 11 patients whose alfentanil requirements varied between 0.108 and 0.22 mg min" 1 , and the duration of surgery and recovery time from end of surgery to opening eyes on command.
RESULTS
We were unable to identify a significant relationship between effective therapeutic infusion and body mass or lean body mass. None of the patients had recall of intraoperative events on explicit questioning either immediately after extubation or 24 h after surgery.
DISCUSSION
We have demonstrated the use of EEG-driven automated feedback controlled delivery of alfentanil during alfentanil-nitrous oxide anaesthesia during surgery. Several years ago, on the basis of pharmacokinetic investigations and clinical experience [11, 12] , our group proposed a target concentration of alfentanil 400-500 ng ml" 1 during anaesthesia with 60% nitrous oxide for major surgery. Given the pharmacokinetic data of Schiittler and Stoeckel [8] , this concentration corresponds to a maintenance infusion rate of approximately O.Hmgmin" 1 for adult patients. Subsequently, several authors have undertaken studies to determine appropriate dose requirements for alfentanil, mostly in combination with 66 % nitrous oxide. They usually used arterial pressure and heart rate for defining additional alfentanil requirements. Ausems, Hug and de Lange [13] reported an average rate of infusion of alfentanil 1.72 (0.15) ug kg" 1 min" 1 (with 66% nitrous oxide) during intra-abdominal surgery (corresponding to 0.123 (0.011) mg min-1 for a patient of 72 kg body weight). Lemmens and colleagues [14] reported, in a group of 18 elderly patients (65-86 yr; average body weight 67 kg), a total requirement of alfentanil 23.5 (10.7) mg for an average duration of anaesthesia of 162 (42) min (with 66% nitrous oxide); this corresponded to an infusion rate of 0.156 mgmin"
1 . Gesink-van der Veer and colleagues [15] found, in patients with Crohn's disease and of average weight 55.8 kg, a mean infusion rate of 2.1 ng kg" 1 min- 1 and, in a control group of average weight 64.4 kg, a mean rate of 1.05 ug kg" 1 min" 1 ; these correspond to infusion rates of 0.151 mg min" 1 and 0.076 mg min" 1 for a 72-kg patient in each group, respectively.
A later study by Ausems and colleagues [16] found that an average rate of infusion of 1.43 (0.55) ug kg' 1 min" 1 for lower abdominal surgery and 1.99 (0.55) ug kg" 1 min" 1 for upper abdominal surgery (with 66% nitrous oxide) was necessary to avoid "response" as defined by a set of criteria reflecting haemodynamic and autonomic changes. These data correspond to infusion rates of 0.1 (0.04) mg min" 1 and 0.14 (0.04) mg min" 1 for a 72-kg patient. Comparison of these data with our study suggests that median EEG frequency may serve as an alternative guide to define appropriate doses of alfentanil during alfentanil-nitrous oxide anaesthesia. Obviously, our data do not allow us to conclude that our mode of administration is superior to repetitive bolus dosing or other infusion techniques. This requires further investigation.
This study and previous ones [5] [6] [7] confirm that feedback controlled drug delivery systems have the potential both to provide clinical anaesthesia and to serve as experimental research tools. Unlike MAC or MIR values, which use quantal responses and cannot define optimum values for achieving anaesthesia in the majority of patients, the effective therapeutic infusion concept uses a therapeutic end-point for evaluating dose requirements. The method determines not only what dose is effective in a given quantile, but also the dose that is effective in all patients.
